Stock screener

BCAX

Conviction 47HealthcareScan · Thu, Sep 24, 2026

Bicara Therapeutics Inc. (BCAX) closed at $19.78 (-3.44%) on Sep 24, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 31, RS Rating 91, -34.9% from its 52-week high, +20.8% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

BCAX$19.78-3.44%
ResistanceSupportVol 14Insider sell
63 bars
3
6
Vol MA14 700.32K
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Bicara Therapeutics Inc.PHARMACEUTICAL PREPARATIONSwww.bicara.com ↗
Price19.78
Change-3.44%
Gap-0.37%
Rel volume3.41×
Avg volume624.73K
Avg $ vol13.98M
SMA 2022.81
SMA 5024.76
SMA 20021.32
Price vs 50-20.10%
Price vs 200-7.23%
MA stackmixed
50/200 cross—
Supertrenddown · 23.86
RSI (14)31
MACD hist-0.20
MACD crossbear · 1d
Stoch %K / %D9 / 15
ADX (14)27
+DI / −DI10 / 29
RSI divergence—
MACD divergenceBullish
ATR %6.65%
ADR %5.16%
52w high30.40
52w low10.70
From 52w high-34.93%
Above 52w low+84.86%
New 52w highNo
SqueezeFired
Bollinger width19.05%
%B-0.20
Donchian pos7.39%
Donchian high25.24
Donchian low19.35
AVWAP (52w high)25.19
vs AVWAP high-21.49%
AVWAP (52w low)20.59
vs AVWAP low-3.94%
OBV trendDown
Chaikin MF (20)-0.14
Today vs 20d3.41×
Avg vol (14d)700.32K
Avg vol (20d)624.73K
Avg $ vol (20d)13.98M
Market cap1.31B
RS Rating91 / 99
RS 3m (vs SPY)-29.40%
RS 6m (vs SPY)-10.93%
RS line new highNo
Trend template4/8
Technical rank28.2
1 week-12.44%
1 month-19.53%
3 months-24.91%
6 months+5.89%
1 year+88.38%
YTD+20.76%
P/E-9.49
P/B2.79
P/S—
P/FCF-12.22
EPS-2.52
Div yield—
ROE-29.43%
ROA-26.93%
Debt/Eq—
Current11.59
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth-102.88%
Price target32.89
Target upside66.28%
Analyst ratingBuy
Institutional113.80%
Ent. value1.21B
Revenue—
Net income-55.44M
Gross profit—
Free cash flow-107.11M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out65.7M
Employees103
ListedFri, Sep 13, 2024
Free float29.77M
Float %47.0%
Short interest10.85M
Days to cover22.1d
Short volume28.3%
Squeeze score80 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.82 vs −$0.77
Last surprise-6.5% miss
Setup gradeC
Conviction47 / 100
Pattern quality—
Tech rank28.2 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance27.69
Support22.06
Days since event—
Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in BCAX

All disclosures →
No recent disclosed trades by Congress in BCAX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in BCAX · open-market 3 sells

InsiderSideShares
Larson Jennifer
Chief Financial Officer · Stock Option (Right to Buy) · 2026-08-12
Grant285K
Cohlhepp Ryan
President and COO · Stock Option (Right to Buy) · 2026-08-10
Exercise18.75K
Mazumdar Claire
Chief Executive Officer · Common Stock · 2026-08-10
Exercise10K
Mazumdar Claire
Chief Executive Officer · Common Stock · 2026-08-10
Sell10K
Mazumdar Claire
Chief Executive Officer · Stock Option (Right to Buy) · 2026-08-10
Exercise10K
Hyep Ivan
Chief Financial Officer · Common Stock · 2026-08-10
Exercise12.5K
Hyep Ivan
Chief Financial Officer · Common Stock · 2026-08-10
Sell12.5K
Hyep Ivan
Chief Financial Officer · Stock Option (Right to Buy) · 2026-08-10
Exercise12.5K
Cohlhepp Ryan
President and COO · Common Stock · 2026-08-10
Exercise18.75K
Cohlhepp Ryan
President and COO · Common Stock · 2026-08-10
Sell18.75K

SEC filings

EDGAR filings in BCAX · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.